Showing results (31-40 of 621) with videos related to
Sort By:
Pageof 63
Frontiers in Immunology|February 2, 2026
Anti-VGLUT2 autoantibodies associated with post-COVID neurocognitive dysfunction: a case reportJeyanthan Charles James, Bianca Teegen, Thivya Pakeerathan, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 6, 2025
Anti-CD19 CAR T-Cell Therapy in Advanced Stiff-Person Syndrome and Concomitant Myasthenia GravisIlya Ayzenberg, Athina-Maria Aloizou, Clarissa Lohmann, et al.Frontiers in Immunology|February 10, 2022
Progressive Retinal and Optic Nerve Damage in a Mouse Model of Spontaneous Opticospinal EncephalomyelitisLaura Petrikowski, Sabrina Reinehr, Steffen Haupeltshofer, et al.Der Nervenarzt|April 12, 2023
[Over one year of B‑cell targeted therapy with Ofatumumab s.c.: first results of a prospective, patient-centered real-world observational study]Rafael Klimas, Anna-Sophia Karl, Philip Lennart Poser, et al.Scientific Reports|October 14, 2025
Retinal degeneration driven by brain-derived neurotrophic factor deficiency in microglia and T-lymphocytesSabrina Reinehr, Julia P Zehge, Katharina Klöster, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2017
Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?Simon Faissner, Yasamin Mahjoub, Manoj Mishra, et al.Expert Review of Neurotherapeutics|December 3, 2013
Multiple sclerosis spasticity epidemiology--key publicationsRalf GoldCNS Drugs|December 7, 2010
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approvedRalf GoldBrain Sciences|June 2, 2021
Differential Diagnosis of Chorea-HIV Infection Delays Diagnosis of Huntington's Disease by YearsJannis Achenbach, Simon Faissner, Carsten SaftPageof 63